Use of Remdesivir in Patients With COVID-19 on Hemodialysis: A Study of Safety and Tolerance

Use of Remdesivir in Patients With COVID-19 on Hemodialysis: A Study of Safety and Tolerance

There are scarce data regarding the use of remdesivir in patients with severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) and end-stage renal disease as US Food and Drug Administration cautions against its use in patients with an estimated glomerular filtration rate 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international reports 2021-03, Vol.6 (3), p.586-593
Hauptverfasser: Aiswarya, Dhanapalan, Arumugam, Venkatesh, Dineshkumar, Thanigachalam, Gopalakrishnan, Natarajan, Lamech, Tanuj Moses, Nithya, Govindasamy, Sastry, Bhagavatula V.R.H., Vathsalyan, Paulpandian, Dhanapriya, Jeyachandran, Sakthirajan, Ramanathan
Format: Artikel
Sprache:eng
Schlagworte:
Clinical Research
COVID-19
dialysis
ESRD
remdesivir
SARS-CoV-2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There are scarce data regarding the use of remdesivir in patients with severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) and end-stage renal disease as US Food and Drug Administration cautions against its use in patients with an estimated glomerular filtration rate 
ISSN:2468-0249
2468-0249
DOI:10.1016/j.ekir.2020.12.003